Humana Inc. (NYSE:HUM) Shares Sold by Public Employees Retirement System of Ohio

Public Employees Retirement System of Ohio lowered its holdings in Humana Inc. (NYSE:HUM - Free Report) by 3.7% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 49,602 shares of the insurance provider's stock after selling 1,919 shares during the period. Public Employees Retirement System of Ohio's holdings in Humana were worth $12,585,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Dodge & Cox grew its position in shares of Humana by 106.7% during the fourth quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider's stock worth $2,587,345,000 after buying an additional 5,264,045 shares in the last quarter. Vanguard Group Inc. increased its position in shares of Humana by 15.8% in the 4th quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider's stock worth $3,254,899,000 after purchasing an additional 1,751,857 shares during the last quarter. Norges Bank acquired a new stake in shares of Humana in the 4th quarter valued at about $416,202,000. Pzena Investment Management LLC lifted its position in shares of Humana by 44.0% during the fourth quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock worth $915,736,000 after purchasing an additional 1,103,132 shares during the last quarter. Finally, Boston Partners lifted its position in shares of Humana by 435.8% during the fourth quarter. Boston Partners now owns 1,098,702 shares of the insurance provider's stock worth $279,236,000 after purchasing an additional 893,637 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Analysts Set New Price Targets

Several analysts have issued reports on HUM shares. Oppenheimer upped their price objective on Humana from $300.00 to $310.00 and gave the company an "outperform" rating in a research note on Thursday, May 1st. Barclays boosted their price target on Humana from $270.00 to $322.00 and gave the company an "equal weight" rating in a report on Friday, April 11th. Royal Bank of Canada restated an "outperform" rating and set a $283.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Truist Financial lowered their target price on shares of Humana from $325.00 to $305.00 and set a "hold" rating for the company in a research note on Monday, May 12th. Finally, JPMorgan Chase & Co. reduced their price target on shares of Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a research report on Tuesday, February 18th. Seventeen research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $286.81.

Humana Price Performance

HUM traded up $2.08 on Thursday, reaching $229.87. The company had a trading volume of 1,266,550 shares, compared to its average volume of 1,724,259. The company has a market capitalization of $27.74 billion, a P/E ratio of 23.10, a PEG ratio of 2.05 and a beta of 0.49. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The company has a fifty day moving average of $258.76 and a 200-day moving average of $267.49. Humana Inc. has a one year low of $212.45 and a one year high of $406.46.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.07 by $1.51. Humana had a net margin of 1.02% and a return on equity of 11.70%. The business had revenue of $32.11 billion during the quarter, compared to analysts' expectations of $32 billion. During the same period last year, the firm posted $7.23 earnings per share. The business's revenue was up 8.4% on a year-over-year basis. As a group, equities research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be issued a $0.885 dividend. The ex-dividend date is Friday, June 27th. This represents a $3.54 annualized dividend and a dividend yield of 1.54%. Humana's dividend payout ratio (DPR) is 25.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.